Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

AMGN - AMGEN Inc.

IEX Last Trade
333.93
2.920   0.874%

Share volume: 2,173,358
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$331.01
2.92
0.88%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
30%
Profitability 54%
Dept financing 25%
Liquidity 29%
Performance 8%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.53%
1 Month
1.56%
3 Months
12.46%
6 Months
23.74%
1 Year
37.36%
2 Year
53.12%
Key data
Stock price
$333.93
P/E Ratio 
57.31
DAY RANGE
$330.22 - N/A
EPS 
$5.81
52 WEEK RANGE
$234.09 - $342.07
52 WEEK CHANGE
$0.38
MARKET CAP 
179.377 B
YIELD 
2.60%
SHARES OUTSTANDING 
537.329 M
DIVIDEND
$2.25
EX-DIVIDEND DATE
08/16/2024
NEXT EARNINGS DATE
11/05/2024
BETA 
0.74
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,724,210
AVERAGE 30 VOLUME 
$1,947,195
Company detail
CEO: Robert Bradway
Region: US
Website: https://www.amgen.com/
Employees: 25,200
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.

Recent news